Publication | Closed Access
Association of Immune-Related Adverse Events With Nivolumab Efficacy in Non–Small-Cell Lung Cancer
978
Citations
11
References
2017
Year
Development of irAEs was associated with survival outcome of nivolumab treatment in patients with advanced or recurrent NSCLC. Further studies are needed to confirm our findings.
| Year | Citations | |
|---|---|---|
Page 1
Page 1